Scott Michael Palmer, MD

Professor of Medicine
Member in the Duke Clinical Research Institute
Vice-Chair for Research in the Department of Medicine
Professor in Immunology
Campus mail 2085 Msrb2 2 Genome Ct, Durham, NC 27710
Phone (919) 684-0245
Email address palme002@mc.duke.edu

Dr. Palmer leads a successful program of clinical, basic and translational research in transplantation and advanced lung diseases. He currently directs the pulmonary research program at the Duke Clinical Research Institute (DCRI) and serves as Vice Chair for Research in the Department of Medicine.

Dr. Palmer has over 150 peer reviewed publications, received numerous awards, including election into the American Society for Clinical Investigation (ASCI) in 2012, chaired many sessions at national and international meetings, serves regularly on NIH study sections, and is on the editorial board of many prominent journals. He is also Associate Director of the Clinical Research Training Program at Duke and has personally mentored over 40 pre-and post-doctoral trainees, many of whom are now engaged in their own successful research careers.

His scientific accomplishments include the first human studies to demonstrate the importance of innate immunity in transplant rejection and completion of a prospective multicenter study that improved CMV prevention after lung transplantation.

Current basic projects in the lab are studying the role of the matrix in the activation of innate immunity in pulmonary transplant rejection, and epithelial injury and repair in the development of toxin induced bronchiolitis obliterans. Translational and human projects are studying predictors of lung transplant survival in the UNOS database, immune monitoring to predict CMV infection and acute rejection after lung transplantation, and the use of novel inhaled antibiotics in lung transplantation. The lab is also using cutting edge whole exome genetic sequencing to identify genetic predictors of transplant rejection.

Dr. Palmer also leads trials coordinated through the DCRI that study the natural history and investigate new treatments for idiopathic pulmonary fibrosis (IPF), chronic lung transplant rejection, and posttransplant cytomegalovirus infection.

Education and Training

  • Fellow, Pulmonary Medicine, Medicine, Duke University, 1996 - 1999
  • Medical Resident, Medicine, Duke University, 1993 - 1996
  • M.H.S., Duke University, 2000
  • M.D., Duke University, 1993

Publications

Hoffman, BM, Stonerock, GL, Smith, PJ, O'Hayer, CVF, Palmer, S, Davis, RD, Kurita, K, Carney, RM, Freeland, K, and Blumenthal, JA. "Development and psychometric properties of the Pulmonary-specific Quality-of-Life Scale in lung transplant patients." Journal of Heart and Lung Transplantation 34, no. 8 (2015): 1058-1065.

Full Text

Durheim, MT, Cyr, DD, Al-Khatib, SM, Thomas, LE, Lopes, RD, Gersh, BJ, Palmer, SM, and Granger, CB. "Chronic Obstructive Pulmonary Disease Is Associated With Increased Risk Of Mortality Among Patients With Atrial Fibrillation: Insights From The Aristotle Trial." 2015.

Scholars@Duke

Durheim, MT, Collard, HR, Roberts, RS, Brown, KK, Flaherty, KR, King, TE, Palmer, SM, Raghu, G, Snyder, LD, Anstrom, KJ, Martinez, FJ, and Investigators, I. "Associations Between Hospitalization And Forced Vital Capacity Endpoints And Survival In Idiopathic Pulmonary Fibrosis." 2015.

Scholars@Duke

Osho, AA, Castleberry, AW, Snyder, LD, Palmer, SM, Stafford-Smith, M, Lin, SS, Duane Davis, R, and Hartwig, MG. "The Chronic Kidney Disease Epidemiology Collaboration (CKDEPI) equation best characterizes kidney function in patients being considered for lung transplantation." Journal of Heart and Lung Transplantation 33, no. 12 (December 1, 2014): 1248-1254.

Full Text

Martinu, T, Gowdy, KM, Nugent, JL, Sun, J, Kinnier, CV, Nelson, ME, Lyes, MA, Kelly, FL, Foster, WM, Gunn, MD, and Palmer, SM. "Role of C-C motif ligand 2 and C-C motif receptor 2 in murine pulmonary graft-versus-host disease after lipopolysaccharide inhalations." American journal of respiratory cell and molecular biology 51, no. 6 (December 2014): 810-821.

PMID
24921973
Full Text

Osho, AA, Castleberry, AW, Snyder, LD, Palmer, SM, Stafford-Smith, M, Lin, SS, Duane Davis, R, and Hartwig, MG. "The Chronic Kidney Disease Epidemiology Collaboration (CKDEPI) equation best characterizes kidney function in patients being considered for lung transplantation." The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 33, no. 12 (December 2014): 1248-1254.

PMID
25107351
Full Text

Smith, PJ, Rivelli, S, Waters, A, Reynolds, J, Hoyle, A, Flowers, M, Davis, RD, Palmer, SM, Mathew, J, Durheim, M, and Blumenthal, JA. "Neurocognitive changes after lung transplantation." Annals of the American Thoracic Society 11, no. 10 (December 2014): 1520-1527.

PMID
25375275
Full Text

Osho, AA, Castleberry, AW, Snyder, LD, Palmer, SM, Ganapathi, AM, Hirji, SA, Lin, SS, Davis, RD, and Hartwig, MG. "Differential outcomes with early and late repeat transplantation in the era of the lung allocation score." The Annals of thoracic surgery 98, no. 6 (December 2014): 1914-1920.

PMID
25442999
Full Text

Meyer, KC, Raghu, G, Verleden, GM, Corris, PA, Aurora, P, Wilson, KC, Brozek, J, Glanville, AR, ISHLT/ATS/ERS BOS Task Force Committee, , and ISHLT/ATS/ERS BOS Task Force Committee, . "An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome." The European respiratory journal 44, no. 6 (December 2014): 1479-1503.

PMID
25359357
Full Text

Singer, JP, Peterson, ER, Snyder, ME, Katz, PP, Golden, JA, D'Ovidio, F, Bacchetta, M, Sonett, JR, Kukreja, J, Shah, L, Robbins, H, Van Horn, K, Shah, RJ, Diamond, JM, Wickersham, N, Sun, L, Hays, S, Arcasoy, SM, Palmer, SM, Ware, LB, Christie, JD, and Lederer, DJ. "Body composition and mortality after adult lung transplantation in the United States." American journal of respiratory and critical care medicine 190, no. 9 (November 2014): 1012-1021.

PMID
25233138
Full Text

Pages